Multicenter, open-label, non-interventional study to evaluate the impact on clinical effects, user-friendliness and patient's acceptance of Airflusal® Forspiro® in the treatment of asthma under real life conditions (ASSURE)

03/02/2016
01/04/2024
EU PAS number:
EUPAS12236
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information